These factors highlight the need for larger, prospective studies with standardized collection of both objective and patient-reported outcomes to confirm and expand our findings
In the U.S., CMS guidance from March 2024 allows Medicare Part D coverage of AOMs with medically accepted indications, such as diabetes or reducing the risk of major adverse cardiovascular events in patients with established cardiovascular disease
Eckert, M
Important safety considerations for transdermal patches: Avoid applying external heat (such as heating pads, hot water bottles, electric blankets, or prolonged sun exposure) to the patch area, as this may increase drug absorption and side effects Do not cut patches or apply additional adhesives unless specifically instructed to do so Wash hands thoroughly after handling patches to avoid transferring medication to eyes or mucous membranes For patients currently using licensed injectable GLP-1 receptor agonists, continue to follow the administration instructions provided in the PIL and by your healthcare team
New advancements in GLP1/GIP medication-based therapies provide a safe and effective way to achieve meaningful results
Excess adipose tissue particularly visceral fat is associated with reduced testosterone levels and impaired fertility in men, making effective weight management especially relevant to male health